Skip to Main Content

Search Our Site

CMS Home En Español Staff

Health

Health-Related Forms & Documents

Asthma Action Plan

AsthmaActionPlan.pdf 381.57 KB (Last Modified on April 25, 2022)

Comments (-1)
Diabetes: Glucometer Testing

Glucometer Testing Letter.pdf 137.82 KB (Last Modified on April 25, 2022)

Comments (-1)
Diabetes: Order and Care Plan

CI 13 Diabetes Order and Care Plan 9.2020_final.pdf 325.07 KB (Last Modified on April 25, 2022)

Comments (-1)
Diet Order

CMS Diet Order.pdf 348.48 KB (Last Modified on November 30, 2022)

Comments (-1)
Health Assessment Transmittal Form ENGLISH (ver2016)

HAForm2016.pdf 39 KB (Last Modified on April 25, 2022)

Comments (-1)
Health Assessment Transmittal Form SPANISH (ver2016)

HATransmittalformParentSecSpanish.pdf 215.51 KB (Last Modified on April 25, 2022)

Comments (-1)
Immunization Requirements (SPANISH)

NC School Vaccine Checklist SPA.jpg 1.47 MB (Last Modified on July 12, 2023)

Comments (-1)
Medication Administration in CMS Schools

Important Information about Medication Administration in CMS Schools .pdf 389.31 KB (Last Modified on April 25, 2022)

Comments (-1)
Medication and Self-carry Authorization Form (April 2017)

Medication and self carry Authorization Form 4 24 2017.pdf 502.61 KB (Last Modified on April 25, 2022)

Comments (-1)
School Health Team Checklist

School Health Team Checklist.pdf 116.2 KB (Last Modified on April 25, 2022)

Comments (-1)
Seizures: Diastat MD Order

Diastat_MD_Order.pdf 234.69 KB (Last Modified on May 6, 2022)

Comments (-1)
Seizures: Emergency Action Plan

CI 21 Seizure EAP and Medication Order 10.2022 Revision.pdf 485.68 KB (Last Modified on October 24, 2022)

Comments (-1)
Severe Allergy: CMS Diet Order 2019

CMS Diet Order 2019.pdf 348.48 KB (Last Modified on April 25, 2022)

Comments (-1)
Severe Allergy: Emergency Action Plan

Severe Allergy EAP 8 2017.pdf 349.39 KB (Last Modified on April 25, 2022)

Comments (-1)
Sickle Cell: Emergency Action Plan

CI25SickleCellEAP7-09.pdf 96.13 KB (Last Modified on April 25, 2022)

Comments (-1)

CLOSE

CLOSE